US further restricts codeine

46189991 - cough and cold medicine
The US Food and Drug Administration has announced measures to limit the use of opioid-containing cough and cold preparations by children The FDA says the safety labelling changes will affect prescription opioid cough and cold medicines containing codeine or hydrocodone. The move follows efforts last year to restrict the use of codeine- or tramadol-containing OTC

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous How CWH and Amcal are owning the pharmacy catalogue space
Next CMs: what are your ethical responsibilities?